{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibt6c6wlchd3zyzduf2lysttdg6zdv72o4ctsj4pnjnmiy7iyjsq4",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mjkv43uqgsh2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreig4uosmebk3txmvmaqdelbevji6qdtvxrpfgg6dwlwbphzaqgyg7y"
    },
    "mimeType": "image/jpeg",
    "size": 725707
  },
  "path": "/news/2026-04-anti-clotting-medication-lowers-added.html",
  "publishedAt": "2026-04-15T17:00:09.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A large international study has found that asundexian, an investigational anti-clotting medication, reduces the risk of a stroke in people who recently experienced a stroke or transient ischemic attack (TIA) caused by a clot forming outside of the heart (non-cardioembolic stroke), without increasing bleeding, the most serious and feared complication of existing stroke prevention treatments.",
  "title": "New anti-clotting medication lowers risk of stroke without added bleeding"
}